GTHP — Guided Therapeutics Share News
0.000.00%
Last trade - 00:00- $18.34m
- $20.43m
- $0.77m
Brief: Guided Therapeutics Signs Agreement To Begin Clinical Trial For Us FDA Approval
Brief: Guided Receives IRB Approval To Start Clinical Study For FDA Approval Of Luviva Advanced Cervical Scan
Brief: Guided Therapeutics Inc Have Applied To List Common Stock On Nasdaq Capital Market
Brief: Guided Therapeutics Says Replaces Convertible Note Facility And Significantly Reduces Dilution
Brief: Guided Therapeutics reports Q4 loss $1.32/shr
Brief: Guided Therapeutics Q2 revenue $103,000 versus $201,000
Brief: Guided therapeutics' distributor signs new four-year deal to sell $10 million of luviva advanced cervical scans to Turkish ministry of health
Brief: Guided Therapeutics announces $4 million private placement
Brief: Guided Therapeutics Q4 loss per share $0.04